153 related articles for article (PubMed ID: 21719255)
1. Tei index in fabry disease.
Niemann M; Breunig F; Beer M; Hu K; Liu D; Emmert A; Herrmann S; Ertl G; Wanner C; Takenaka T; Tei C; Weidemann F
J Am Soc Echocardiogr; 2011 Sep; 24(9):1026-32. PubMed ID: 21719255
[TBL] [Abstract][Full Text] [Related]
2. Importance of left ventricular activation in determining myocardial performance (Tei) index: comparison with total isovolumic time.
Duncan AM; Francis DP; Henein MY; Gibson DG
Int J Cardiol; 2004 Jun; 95(2-3):211-7. PubMed ID: 15193822
[TBL] [Abstract][Full Text] [Related]
3. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
4. Relation of mitral valve prolapse to basal left ventricular hypertrophy as determined by cardiac magnetic resonance imaging.
Zia MI; Valenti V; Cherston C; Criscito M; Uretsky S; Wolff S
Am J Cardiol; 2012 May; 109(9):1321-5. PubMed ID: 22335854
[TBL] [Abstract][Full Text] [Related]
5. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.
Weidemann F; Breunig F; Beer M; Sandstede J; Störk S; Voelker W; Ertl G; Knoll A; Wanner C; Strotmann JM
Eur Heart J; 2005 Jun; 26(12):1221-7. PubMed ID: 15728649
[TBL] [Abstract][Full Text] [Related]
6. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
7. Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease.
Krämer J; Niemann M; Liu D; Hu K; Machann W; Beer M; Wanner C; Ertl G; Weidemann F
Eur Heart J; 2013 Jun; 34(21):1587-96. PubMed ID: 23520186
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
[TBL] [Abstract][Full Text] [Related]
9. Effect of cilnidipine on left ventricular function in hypertensive patients as assessed by tissue Doppler Tei index.
Tan HW; Li L; Zhang W; Ma ZY; Zhong XZ; Zhang Y
J Hum Hypertens; 2006 Aug; 20(8):618-24. PubMed ID: 16625238
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions.
Kirschbaum SW; Baks T; van den Ent M; Sianos G; Krestin GP; Serruys PW; de Feyter PJ; van Geuns RJ
Am J Cardiol; 2008 Jan; 101(2):179-85. PubMed ID: 18178403
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopy.
Petritsch B; Köstler H; Machann W; Horn M; Weng AM; Goltz JP; Hahn D; Niemann M; Weidemann F; Wanner C; Beer M
Rofo; 2012 Nov; 184(11):1020-5. PubMed ID: 22893488
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of global and regional left ventricular function with a 16-slice spiral-CT using two different software tools for quantitative functional analysis and qualitative evaluation of wall motion changes in comparison with magnetic resonance imaging].
Koch K; Oellig F; Kunz P; Bender P; Oberholzer K; Mildenberger P; Hake U; Kreitner KF; Thelen M
Rofo; 2004 Dec; 176(12):1786-93. PubMed ID: 15573290
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease.
Tacke CE; Romeih S; Kuipers IM; Spijkerboer AM; Groenink M; Kuijpers TW
Circ Cardiovasc Imaging; 2013 Jan; 6(1):67-73. PubMed ID: 23197079
[TBL] [Abstract][Full Text] [Related]
14. Tei-Index in coronary artery disease--validation in patients with overall cardiac and isolated diastolic dysfunction.
Bruch C; Schmermund A; Dagres N; Katz M; Bartel T; Erbel R
Z Kardiol; 2002 Jun; 91(6):472-80. PubMed ID: 12219695
[TBL] [Abstract][Full Text] [Related]
15. Functional description of the left ventricle in patients with volume overload, pressure overload, and myocardial disease using cine magnetic resonance imaging.
Wagner S; Auffermann W; Buser P; Semelka RC; Higgins CB
Am J Card Imaging; 1991 Jun; 5(2):87-97. PubMed ID: 10147590
[TBL] [Abstract][Full Text] [Related]
16. Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy.
Tigen K; Karaahmet T; Kirma C; Dundar C; Pala S; Isiklar I; Cevik C; Kilicgedik A; Basaran Y
J Am Soc Echocardiogr; 2010 Apr; 23(4):416-22. PubMed ID: 20149594
[TBL] [Abstract][Full Text] [Related]
17. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
[TBL] [Abstract][Full Text] [Related]
18. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study.
Mishra RK; Kizer JR; Palmieri V; Roman MJ; Galloway JM; Fabsitz RR; Lee ET; Best LG; Devereux RB
Echocardiography; 2007 Apr; 24(4):340-7. PubMed ID: 17381641
[TBL] [Abstract][Full Text] [Related]
19. Late enhancement detected by cardiac magnetic resonance imaging in acute myocarditis mimicking acute myocardial infarction: location patterns and lack of correlation with systolic function.
Camastra GS; Cacciotti L; Marconi F; Sbarbati S; Pironi B; Ansalone G
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1029-33. PubMed ID: 18163015
[TBL] [Abstract][Full Text] [Related]
20. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
